Allergan Management Discusses Q4 2011 Results – Earnings Call Transcript
Allergan Management Discusses Q4 2011 Results – Earnings Call Transcript
OZURDEX, since the last earnings call, has been approved either for retinal vein occlusion or retinal vein occlusion and uveitis in several countries, namely Canada, Israel, Switzerland, Singapore, Mexico, Chile and Sri Lanka.
Read more on Seeking Alpha
Related posts:
- call me weird… ch_client = "wildplus"; ch_width = 250; ch_height = 250; ch_type = "mpu"; ch_sid = "WhatisHyperhidrosis 250x250"; ch_color_site_link = "#236B9F"; ch_color_title...
- I Want This NOW! ...
- Non-Surgical Management of Your Underarm Hyperhidrosis underarmsweating.ie Axillary Hyperhidrosis is the medical term for excessively sweaty armpits. Everyone sweats; that’s a fact of life. It is...
- Primary focal hyperhidrosis: diagnosis and management.(Clinical Management)(Clinical report): An article from: Dermatology Nursing Primary focal hyperhidrosis: diagnosis and management.(Clinical Management)(Clinical report): An article from: Dermatology Nursing This digital document is an article from...
- Stroke & hyperhidrosis: two distinctively different conditions present their own set of problems.(HOUSE CALL): An article from: Ebony Stroke & hyperhidrosis: two distinctively different conditions present their own set of problems.(HOUSE CALL): An article from: Ebony This digital...